Related Experiment Video
Updated: May 29, 2026

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Immunomodulation by poly-YE reduces organophosphate-induced brain damage
Arseny Finkelstein1, Gilad Kunis, Tamara Berkutzki
1Department of Neurobiology, The Weizmann Institute of Science, Rehovot 76100, Israel.
Brain, Behavior, and Immunity
|September 20, 2011
Summary
A novel immunomodulatory treatment, poly-YE, significantly reduced organophosphate-induced brain damage in rats by promoting neuronal survival and preserving tissue. This approach targets T regulatory cells (Tregs) to mitigate neuroinflammation and neurological deficits.
Area of Science:
- Neuroscience
- Immunology
- Toxicology
Background:
- Organophosphate poisoning from environmental, occupational, or deliberate exposure poses a significant threat, with no effective therapies currently available.
- Exposure can cause brain damage, microglial activation, and long-term neurological deficits.
- Adaptive immunity can regulate microglial responses, potentially mitigating central nervous system (CNS) damage.
Purpose of the Study:
- To investigate if an immunization-based treatment modulating T regulatory cells (Tregs) can reduce organophosphate-induced brain damage.
- To evaluate poly-YE as a supplementary therapy to standard antidotal protocols.
Main Methods:
- Rats were intoxicated with soman or paraoxon.
- After 24 hours, rats received a single injection of the immunomodulator poly-YE.
- Brain damage, neuronal survival, microglial activation, T cell infiltration, and BDNF levels were assessed.
Main Results:
- Poly-YE treatment significantly increased neuronal survival and tissue preservation.
- The treatment led to reduced microglial activation and specific recruitment of CD4(+) T cells into the brain.
- Increased levels of brain-derived neurotrophic factor (BDNF) were observed in the piriform cortex.
Conclusions:
- Poly-YE demonstrates therapeutic potential as an immunomodulatory supplement against organophosphate-induced brain damage.
- This approach may offer a novel strategy to mitigate the severe consequences of organophosphate intoxication.
- Targeting T regulatory cells offers a promising avenue for neuroprotection in poisoning events.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
